on 06 Jun 2023
Last Applicant/ Owned by
Semmelweisstrasse 7
Planegg
DE
D-82152
Serial Number
97042228 filed on 23rd Sep 2021
Registration Number
7071326 registered on 06th Jun 2023
Correspondent Address
Michael J. Leonard
Filing Basis
1. intent to use
Disclaimer
NO DATA
reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines Read More
Pharmaceutical research and development of pharmaceutical preparations, medicines and vaccines; providing medical and scientific research information; Scientific research in the nature of conducting clinical trials for others; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; research and design services, namely, research and development in the field of antibodies and clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis
reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines
pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceuticals comprising small molecules for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; small molecule compounds for use as drug delivery agents in pharmaceuticals; small molecule compounds being pharmaceuticals for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis in humans; small molecule pharmaceuticals for the treatment of diseases and conditions, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Clinical medical reagents; Biological preparations for medical purposes, namely, for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceutical and veterinary preparations, agents and substances for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis
No 97042228
No Service Mark
No 114353.00147
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Jun 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th Jun 2023 | REGISTERED-PRINCIPAL REGISTER |
21st Mar 2023 | PUBLISHED FOR OPPOSITION |
21st Mar 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
01st Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
13th Feb 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
10th Feb 2023 | EXAMINERS AMENDMENT -WRITTEN |
10th Feb 2023 | EXAMINERS AMENDMENT E-MAILED |
10th Feb 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
10th Feb 2023 | EXAMINER'S AMENDMENT ENTERED |